HK/China Healthcare Analyst (ex-Fosun Pharma)

Xinyao (Criss) Wang

Equity Capital Markets

Suzhou Basecare Medical / Equity Capital Markets

<p>In September 2020, <a href="https://www.smartkarma.com/entities/suzhou-basecare-medical-corporation-limited" target="_blank" data-smartkarma-citation="entities:31087:1" rel="noopener">Suzhou Basecare Medical (MED CH)</a> applied to list on the Hong Kong Stock Exchange. As a leading enterprise in the assisted reproduction field of NGS market segment, the Company is committed to the R&amp;D and clinical application of high-throughput sequencing technology in the reproductive field, and is also a "unicorn" enterprise in Suzhou. The following analyzed both the strengths and concerns for Basecare.</p>

In September 2020, Suzhou Basecare Medical (MED CH) applied to list on the Hong Kong Stock Exchange. As a leading enterprise in the assisted reproduction field of NGS market segment, the Company is committed to the R&amp;D and clinical application of high-throughput sequencing technology in the reproductive field, and is also a "unicorn" enterprise in Suzhou. The following analyzed both the strengths and concerns for Basecare.

Pre-IPO Basecare Medical - Here Are the the Strengths and Concerns

China

Suzhou Basecare Medical Corporation Limited operates as a genetic technology researching company. The Company provides a comprehensive clinical solution for reproductive health. Suzhou Basecare Medical also develops and markets innovative medical devices.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Suzhou Basecare Medical (1862702D CH)

Pre-IPO Basecare Medical - Here Are the the Strengths and Concerns

This article analyzed Basecare's strengths and concerns in terms of its core products, financial position, commercialization and the current...

Xinyao (Criss) Wang

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)